18F-FDG uptake in reactive neck lymph nodes of oral cancer: Relationship to lymphoid follicles

Journal of Nuclear Medicine

Volumn 49, Issue 7, 2008, Pages 1053-1059

  Nakagawa, Tassei ^a,b,c   Yamada, Masatoshi ^a   Suzuki, Yoshio ^a  

^a ASAHI GENERAL HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NONE

Author keywords

Follicular dendritic cell; Germinal center; Glucose transporter; Oncology; PET CT; Reactive lymphadenopathy

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; SLC2A1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER SURGERY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH FOLLICLE; LYMPHADENOPATHY; MACROPHAGE; MALE; METASTASIS; MOUTH CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOSYNTHESIS; LYMPH NODE; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; NECK; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 46749130934     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.049718     Document Type: Article

References (29)

1. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305-332.
2. Mueckler M. Facilitative glucose transporters. Eur J Biochem. 1994;219:713-725.
3. Smith TA. Facilitative glucose transporter expression in human cancer tissue. Br J Biomed Sci. 1999;56:285-292.
4. 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255-1260.
5. Schöder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65-72.
6. 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck. 2007;29:203-210.
7. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
8. 18F-FDG PET results in lung cancer staging. J Nucl Med. 2004;45:999-1003.
9. Chung JH, Lee WW, Park SY, et al. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer. Eur J Surg Oncol. 2006;32:989-995.
10. von der Walk P, Meijer CJLM. Lymph nodes. In: Mills SE, ed. Histology for Pathologists. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:763-780.
11. Mason DY, Cordell JL, Brown MH, et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995;86:1453-1459.
12. Steward M, Bishop R, Piggott NH, et al. Production and characterization of a new monoclonal antibody effective in recognizing the CD3 T-cell associated antigen in formalin-fixed embedded tissue. Histopathology. 1997;30:16-22.
13. Pulford KA, Rigney EM, Micklem KJ, et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 1989;42:414-421.
14. Maeda K, Matsuda M, Suzuki H, et al. Immunohistochemical recognition of human follicular dendritic cell (FDCs) in routinely processed paraffin sections. J Histochem Cytochem. 2002;50:1475-1485.
15. Som PM, Curtin HD, Mancuson AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR. 2000;174:837-845.
16. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26:1345-1348.
17. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-1417.
18. Ma SY, See LC, Lai CH, et al. Delayed 18F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med. 2003;44:1775-1783.
19. Vermeersch H, Loose D, Ham H, et al. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med Mol Imaging. 2003;30:1689-1700.
20. Schöder H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004;34:180-197.
21. 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck. 2002;24:345-349.
22. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47:755-762.
23. Nahmias C, Carlson ER, Duncan LD, et al. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer. J Oral Maxillofac Surg. 2007;65:2524-2535.
24. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity. 2007;27:190-202.
25. Garside P, Ingulli E, Merica RR, et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 1998;281:96-99.
26. Cyster JG, Ansel KM, Reif K, et al. Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev. 2000;176:181-193.
27. Vinuesa CG, Cook MC. The molecular basis of lymphoid architecture and B cell responses: implications for immunodeficiency and immunopathology. Curr Mol Med. 2001;1:689-725.
28. Li L, Choi YS. Follicular dendritic cell-signaling molecules required for proliferation and differentiation of GC-B cells. Semin Immunol. 2002;14:259-266.
29. Kosco-Vilbois MH. Are follicular dendritic cells really good for nothing? Nat Rev Immunol. 2003;3:764-769.